Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,054 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing success.
Roberts J, Fenton G. Roberts J, et al. Nurs Stand. 2010 May 5-11;24(35):64. doi: 10.7748/ns.24.35.64.s57. Nurs Stand. 2010. PMID: 20509387 No abstract available.
Practical approach.
Roberts J, Fenton G. Roberts J, et al. Emerg Nurse. 2010 May;18(2):38. doi: 10.7748/en.18.2.38.s22. Emerg Nurse. 2010. PMID: 20527456 No abstract available.
Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the S. aureus Network Adaptive Platform (SNAP) randomized controlled trial.
Anpalagan K, Dotel R, MacFadden DR, Smith S, Voss L, Petersiel N, Marks M, Marsh J, Mahar RK, McGlothlin A, Lee TC, Goodman A, Morpeth S, Davis JS, Tong SYC, Bowen AC; SNAP Adjunctive Clindamycin Domain-Specific Working Group; SNAP Trial Global Trial Steering Committee. Anpalagan K, et al. Clin Infect Dis. 2024 May 27:ciae289. doi: 10.1093/cid/ciae289. Online ahead of print. Clin Infect Dis. 2024. PMID: 38801783
Costs and Impact of Disease in Adults with Sickle Cell Disease: A Pilot Study.
Lanzkron S, Crook N, Wu J, Hussain S, Curtis R, Robertson D, Baker JR, Nugent D, Soni A, Roberts JC, Ullman M Ms, Kanter J, Nichol M. Lanzkron S, et al. Among authors: roberts jc. Blood Adv. 2024 May 22:bloodadvances.2023012477. doi: 10.1182/bloodadvances.2023012477. Online ahead of print. Blood Adv. 2024. PMID: 38776399
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
10,054 results
You have reached the last available page of results. Please see the User Guide for more information.